scholarly article | Q13442814 |
P50 | author | Naohisa Hosomi | Q42853794 |
P2093 | author name string | Masakazu Kohno | |
Tsutomu Takahashi | |||
Peng Guo | |||
Camelia R Ban | |||
Takayuki Naya | |||
Xiao-yu R Song | |||
P2860 | cites work | TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways | Q24317441 |
Disruption of epithelial cell-matrix interactions induces apoptosis | Q24673611 | ||
Tumor necrosis factor alpha induces a metalloprotease-disintegrin, ADAM8 (CD 156): implications for neuron-glia interactions during neurodegeneration | Q28142160 | ||
Reversible middle cerebral artery occlusion without craniectomy in rats | Q28268048 | ||
Cellular localization of tumor necrosis factor alpha following focal cerebral ischemia in mice | Q32026749 | ||
Morbillivirus infection of the mouse central nervous system induces region-specific upregulation of MMPs and TIMPs correlated to inflammatory cytokine expression | Q33853754 | ||
Potential of anticytokine therapies in central nervous system ischaemia | Q34452055 | ||
RETRACTED: A new mechanism of neurodegeneration: a proinflammatory cytokine inhibits receptor signaling by a survival peptide | Q36438395 | ||
Microvascular basal lamina antigens disappear during cerebral ischemia and reperfusion | Q36670336 | ||
Inhibition of anchorage-dependent cell spreading triggers apoptosis in cultured human endothelial cells | Q36676242 | ||
Elevated expression of membrane type 1 metalloproteinase (MT1-MMP) in reactive astrocytes following neurodegeneration in mouse central nervous system | Q40852287 | ||
Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Effects of tumour necrosis factor alpha, interleukin 1 and phorbol ester | Q41057155 | ||
Activation systems for latent matrix metalloproteinase-2 are upregulated immediately after focal cerebral ischemia. | Q42453965 | ||
Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion | Q42494764 | ||
Metalloproteinase inhibition blocks edema in intracerebral hemorrhage in the rat. | Q42550130 | ||
Production of MMPs in human cerebral endothelial cells and their role in shedding adhesion molecules | Q43577432 | ||
Prolonged activation of jun and collagenase genes by tumour necrosis factor-alpha | Q43819767 | ||
Tumor necrosis factor-alpha expression in ischemic neurons | Q48094066 | ||
Tumor necrosis factor alpha expression produces increased blood-brain barrier permeability following temporary focal cerebral ischemia in mice | Q48196714 | ||
Protein extravasation and cellular uptake after high-dose human-albumin treatment of transient focal cerebral ischemia in rats | Q48215449 | ||
Pathophysiological process after transient ischemia of the middle cerebral artery in the rat. | Q48221373 | ||
Experimental cerebral infarctioneffects of pentobarbital in Mongolian gerbils | Q48288391 | ||
Ischemic and excitotoxic brain injury is enhanced in mice lacking the p55 tumor necrosis factor receptor | Q48331119 | ||
Effect of brain edema on infarct volume in a focal cerebral ischemia model in rats | Q48365404 | ||
Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury | Q48698077 | ||
TNF-alpha pretreatment induces protective effects against focal cerebral ischemia in mice | Q48714135 | ||
Early TNF-alpha levels correlate with ischaemic stroke severity | Q48720718 | ||
Duration threshold of induced hypertension on cerebral blood flow, energy metabolism, and edema after transient forebrain ischemia in gerbils | Q48882732 | ||
Inhibition of tumor necrosis factor-alpha reduces focal cerebral ischemic injury in the spontaneously hypertensive rat. | Q48887459 | ||
Immunohistochemistry of matrix metalloproteinases in reperfusion injury to rat brain: activation of MMP-9 linked to stromelysin-1 and microglia in cell cultures | Q48973809 | ||
Hypoxic preconditioning protects cultured neurons against hypoxic stress via TNF-alpha and ceramide. | Q54064844 | ||
Proteolytic cascade enzymes increase in focal cerebral ischemia in rat | Q71059039 | ||
Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors | Q71169977 | ||
Tumor necrosis factor-alpha-induced gelatinase B causes delayed opening of the blood-brain barrier: an expanded therapeutic window | Q71289958 | ||
Inhibition of tumor necrosis factor and amelioration of brain infarction in mice | Q73089295 | ||
Mitogen-activated protein kinases mediate matrix metalloproteinase-9 expression in vascular smooth muscle cells | Q73295316 | ||
Microglia and macrophages are the major source of tumor necrosis factor in permanent middle cerebral artery occlusion in mice | Q73315270 | ||
Development of anti-TNF therapy for rheumatoid arthritis | Q74187188 | ||
Evolution of cerebral tumor necrosis factor-alpha production during human ischemic stroke | Q74312789 | ||
Anti-TNF-alpha antibodies suppress the development of experimental autoimmune myasthenia gravis | Q78631880 | ||
P433 | issue | 8 | |
P921 | main subject | Taking acetaminophen after smoking cannabis | Q979168 |
cerebral infarction | Q1209150 | ||
P304 | page(s) | 959-967 | |
P577 | publication date | 2005-08-01 | |
P1433 | published in | Journal of Cerebral Blood Flow & Metabolism | Q14663525 |
P1476 | title | Tumor necrosis factor-alpha neutralization reduced cerebral edema through inhibition of matrix metalloproteinase production after transient focal cerebral ischemia | |
P478 | volume | 25 |
Q42594826 | Adenosine and stroke: maximizing the therapeutic potential of adenosine as a prophylactic and acute neuroprotectant |
Q34584715 | Anti-inflammatory effects of Edaravone and Scutellarin in activated microglia in experimentally induced ischemia injury in rats and in BV-2 microglia |
Q91815195 | Astaxanthin Ameliorates Ischemic-Hypoxic-Induced Neurotrophin Receptor p75 Upregulation in the Endothelial Cells of Neonatal Mouse Brains |
Q30724766 | BAFF, APRIL, TWEAK, BCMA, TACI and Fn14 proteins are related to human glioma tumor grade: immunohistochemistry and public microarray data meta-analysis |
Q39037187 | Barrier function in the peripheral and central nervous system-a review. |
Q35194742 | Combination treatment with low-dose Niaspan and tissue plasminogen activator provides neuroprotection after embolic stroke in rats. |
Q33716712 | Correlation Between Cannabidiol-Induced Reduction of Infarct Volume and Inflammatory Factors Expression in Ischemic Stroke Model |
Q64231649 | Does Pretreatment with a Tumor Necrosis Factor Alpha-inhibitor Improve the Outcome After Ischemic Cerebral Infarction? A Case Report |
Q50279810 | Escin attenuates cerebral edema induced by acute omethoate poisoning |
Q50326132 | Etanercept Prevents Histopathological Damage after Spinal Cord Injury in Rats. |
Q33378976 | Focal cerebral ischemia in the TNFalpha-transgenic rat. |
Q90049912 | Heat-Shock Proteins in Neuroinflammation |
Q39512224 | IL-1β down-regulates ADAMTS-13 mRNA expression in cells of the central nervous system. |
Q58799486 | Inflammatory molecules might become both biomarkers and therapeutic targets for stroke management |
Q47629377 | Intra-cerebral cannabidiol infusion-induced neuroprotection is partly associated with the TNF-α/TNFR1/NF-кB pathway in transient focal cerebral ischaemia |
Q48165537 | Iptakalim protects against ischemic injury by improving neurovascular unit function in the mouse brain |
Q37183365 | LXW7 ameliorates focal cerebral ischemia injury and attenuates inflammatory responses in activated microglia in rats |
Q38431768 | Matrix Metalloproteinase-8 is a Novel Pathogenetic Factor in Focal Cerebral Ischemia |
Q53316266 | Matrix metalloproteinase-β19 expressed in cerebral amyloid angiopathy. |
Q38262241 | Minocycline attenuates brain tissue levels of TNF-α produced by neurons after prolonged hypothermic cardiac arrest in rats |
Q89126912 | Modulation of brain ACE and ACE2 may be a promising protective strategy against cerebral ischemia/reperfusion injury: an experimental trial in rats |
Q37056974 | Molecular physiology of preconditioning-induced brain tolerance to ischemia |
Q35116500 | Neuroprotection in a rabbit model of intraventricular haemorrhage by cyclooxygenase-2, prostanoid receptor-1 or tumour necrosis factor-alpha inhibition |
Q53414386 | Neuroprotective Effects of (-)-Epigallocatechin-3-Gallate Against Focal Cerebral Ischemia/Reperfusion Injury in Rats Through Attenuation of Inflammation. |
Q34079520 | Niaspan treatment induces neuroprotection after stroke |
Q93358519 | Post-stroke inflammation-target or tool for therapy? |
Q42434906 | Preischemic induction of TNF-alpha by physical exercise reduces blood-brain barrier dysfunction in stroke |
Q39250156 | Regional TNFα mapping in the brain reveals the striatum as a neuroinflammatory target after ventricular fibrillation cardiac arrest in rats. |
Q55116313 | SUR1-TRPM4 channel activation and phasic secretion of MMP-9 induced by tPA in brain endothelial cells. |
Q38814573 | Scutellarin as a Potential Therapeutic Agent for Microglia-Mediated Neuroinflammation in Cerebral Ischemia |
Q35757950 | Secretory phospholipase A2 IIA is up-regulated by TNF-alpha and IL-1alpha/beta after transient focal cerebral ischemia in rat. |
Q48473077 | Soluble or soluble/membrane TNF-α inhibitors protect the brain from focal ischemic injury in rats. |
Q34990855 | TNFR1-JNK signaling is the shared pathway of neuroinflammation and neurovascular damage after LPS-sensitized hypoxic-ischemic injury in the immature brain. |
Q33824991 | Targeting microglial activation in stroke therapy: pharmacological tools and gender effects |
Q34335614 | The dual role of the neuroinflammatory response after ischemic stroke: modulatory effects of hypothermia |
Q35751937 | The harms and benefits of inflammatory and immune responses in vascular disease |
Q36369776 | The microRNA miR-181c controls microglia-mediated neuronal apoptosis by suppressing tumor necrosis factor |
Q42325031 | The neuroprotective effects of Tao-Ren-Cheng-Qi Tang against embolic stroke in rats |
Q36925788 | Tissue plasminogen activator (tPA) and matrix metalloproteinases in the pathogenesis of stroke: therapeutic strategies |
Q37618722 | Toll-like receptor 7 preconditioning induces robust neuroprotection against stroke by a novel type I interferon-mediated mechanism |
Q39042361 | Treatment of acute cerebral ischemia using animal models: a meta-analysis |
Search more.